NCT06006208

Brief Summary

This is a clinical trial to compare the oxygenation and ventilation performance between manual ventilation and mechanical ventilation when transporting cardiac patients to the ICU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 23, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 9, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
7 months until next milestone

Results Posted

Study results publicly available

December 4, 2025

Completed
Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

11 months

First QC Date

August 6, 2023

Results QC Date

July 20, 2025

Last Update Submit

January 31, 2026

Conditions

Keywords

ventilatorpoint of care ultrasoundtransport

Outcome Measures

Primary Outcomes (1)

  • The % Change in Mean Artery Blood Pressure

    The % change in mean artery blood pressure before and after the transport to the ICU. i.e. (post-transport measurement - pre-transport measurement)/pre-transport measurement x100 (%)

    Pre-transport hemodynamic values were averaged from the final three readings (taken at 1-min intervals) before switching to the transport monitor, and post-transport readings were recorded immediately after transfer to the ICU monitor.

Secondary Outcomes (4)

  • The % Changes in PaO2/FiO2 (P/F Ratio)

    First aortic blood gas analysis Immediately before transport to ICU till the second arterial blood gas analysis after dropping off the patient at ICU; approximately 30 minutes after the first visual assessment.

  • The % Change in PaCO2

    First aortic blood gas analysis Immediately before transport to ICU till the second arterial blood gas analysis after dropping off the patient at ICU; approximately 30 minutes after the first visual assessment.

  • The Visual Scale in Changes in Left Ventricular Function

    First visual assessment of left ventricular function Immediately before transport to ICU till the second visual assessment after dropping off the patient at ICU; approximately 30 minutes after the first visual assessment.

  • The Visual Scale in Changes in Right Ventricular Function

    First visual assessment of right ventricular function Immediately before transport to ICU till the second visual assessment after dropping off the patient at ICU; approximately 30 minutes after the first visual assessment.

Study Arms (2)

Arm 1: AMBU bag manual ventilation during transport to the ICU

NO INTERVENTION

Arm 2: Hamilton C1 ventilator during transport to the ICU

EXPERIMENTAL
Device: Hamilton C1 ventilator during transport to the ICU

Interventions

Instead of AMBU bag manual ventilation during transport to the ICU, intervention is using Hamilton C1 ventilator during transport to the ICU

Arm 2: Hamilton C1 ventilator during transport to the ICU

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years old (any gender or race)
  • Cardiac surgery
  • Require postoperative mechanical ventilation and care in the ICU.

You may not qualify if:

  • Patients' refusal
  • Extubation in OR
  • On mechanical circulatory support
  • Requirement for postoperative therapy with inhaled pulmonary vasodilators (epoprostenol (FLOLAN), inhaled nitric oxide, etc.)
  • Severe RV dysfunction with preoperative echocardiography
  • Contraindication to TEE and pulmonary artery catheter.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

Results Point of Contact

Title
Associate Professor
Organization
Thomas Jefferson University

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patients will be randomly assigned to 2 arms above and the patients are not informed about which arm they are assigned.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: After IRB approval and obtaining a written informed consent, patients will be randomly assigned to the one of the following 2 arms. However, AMBU bag arm patients may be switched to Hamilton C1 at an anesthesia provider's discretion based on post cardiopulmonary bypass right ventricular function, PaO2/FiO2, and PaCO2. These patients will be excluded from the AMBU bag arm. Arm 1: AMBU bag manual ventilation during transport to the ICU Arm 2: Hamilton C1 ventilator during transport to the ICU
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

August 6, 2023

First Posted

August 23, 2023

Study Start

November 1, 2023

Primary Completion

October 9, 2024

Study Completion

April 30, 2025

Last Updated

February 3, 2026

Results First Posted

December 4, 2025

Record last verified: 2026-01

Locations